Rita E. Numerof, PhD

home / authors / rita-e-numerof-phd-1

Rita E. Numerof, PhD, is the president at Numerof & Associates, Inc.

Articles

The Affordable Care Act's Impact on Innovation in Biopharma

The Affordable Care Act's Impact on Innovation in Biopharma

Michael N. Abrams;Rita E. Numerof, PhD;Jill E. Sackman, PhD
February 1st 2014

The biopharmaceutical industry contemplates product innovation within the changing landscape of healthcare.

Site Logo

The Growing Orphan-Drug Paradigm

Michael N. Abrams;Rita E. Numerof, PhD
April 1st 2012

Rather than seeking a single indication for one large group, the orphan-drug approach segments the market for a drug more minutely.

bp0510_finalword_J_Sackman-667238-1408638359869.jpg

Are You Ready for a Post-Reform World?

Rita E. Numerof, PhD;Jill E. Sackman, PhD
May 1st 2010

The industry must be prepared for the impact of the sweeping changes expected from the new legislation.

Latest Updated Articles

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: December 9th 2024 | Updated: December 22nd 2024
Recap Key Industry Trends for Viral Clearance and NGS
Shining Pro - Stock.Adobe.com
Published: December 7th 2024 | Updated: December 22nd 2024
Enhancing Quality Through Training
Published: July 20th 2020 | Updated: December 22nd 2024
Contact BioPharm International Editors
Published: July 19th 2020 | Updated: December 22nd 2024
Editorial Information: BioPharm International Submission Guidelines and Editorial Calendars
© 2024 MJH Life Sciences

All rights reserved.